Hirsutism

    Azadeh Mofid, S. A. Seyyed Alinaghi, S. Zandieh, Tahereh Yazdani
    Image of study
    TLDR Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.
    Hirsutism, characterized by excessive male-pattern hair growth in women, is primarily caused by hyperandrogenemia, with polycystic ovary syndrome and idiopathic hirsutism being the most common culprits. It can lead to significant psychological distress if left untreated. Diagnosis involves a thorough history, examination, and targeted investigations, with a serum testosterone level above 150 ng/dl indicating the need for further tests to rule out an androgen-secreting tumor. Treatment typically involves a combination of lifestyle changes, androgen suppression, peripheral androgen blockage, and cosmetic approaches, with patients advised that improvements may take 3–6 months and ongoing treatment may be necessary to maintain results. The document provides an overview of the condition, its causes, diagnostic process, and management strategies, along with the authors' recommendations.
    Discuss this study in the Community →

    Research cited in this study

    18 / 18 results

    Related Community Posts Join

    6 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Related Research

    2 / 2 results